查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1888083

2025年全球藥物重定位人工智慧市場報告

Artificial Intelligence In Drug Repurposing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，人工智慧在藥物重定位領域的市場規模迅速擴張，預計將從2024年的8.7億美元成長到2025年的10.5億美元，複合年成長率達20.5%。這一成長歸因於慢性病和罕見疾病病例的增加、研發投入的增加、監管支持的加強、醫療保健成本的上升以及製藥公司與人工智慧公司之間合作的加強等因素。

預計未來幾年，人工智慧在藥物重定位領域的市場規模將呈指數級成長，到2029年將達到21.9億美元，複合年成長率（CAGR）為20.2%。預測期內的成長要素包括：對經濟高效的藥物開發需求不斷成長、基於人工智慧的預測分析得到廣泛應用、疾病複雜性日益增加、雲端基礎設施的普及以及現有已獲認證核可藥的再利用機會不斷增加。預測期內的關鍵趨勢包括：機器學習和生成式人工智慧應用的創新、預測建模和數據分析的進步、用於假設生成的大規模語言模型的技術進步、雲端基礎的人工智慧藥物發現平台的創新以及多體學數據整合系統的技術改進。

未來幾年，精準醫療需求的不斷成長預計將推動人工智慧在藥物重定位領域的市場發展。精準醫療是一種基於個人獨特基因、行為和環境來客製化疾病預防和治療方案的醫療方法。隨著患者和醫療服務提供者越來越傾向於根據個體的基因特徵和生活方式量身定做治療方案，以提高療效並減少副作用，個人化治療的日益普及正在推動精準醫療的擴張。人工智慧在藥物重定位領域的治療方法，透過識別與個別基因和分子特徵相符的現有藥物，為精準醫療提供支持，從而實現更精準、更個人化的治療方案。例如，根據美國非營利組織個人化醫療聯盟（Personalized Medicine Coalition）的數據顯示，截至2024年2月，美國食品藥物管理局（FDA）在2023年核准了16種針對罕見疾病的個人化治療方案，較2022年的6種核准增加。因此，精準醫療需求的不斷成長正在推動人工智慧在藥物重定位領域的市場發展。

在藥物重定位人工智慧市場中，主要企業致力於將先進技術整合到藥物重定位領域，例如電腦輔助藥物重定位系統。該系統透過對文獻和生物資訊進行數據驅動分析，系統地識別現有藥物的新治療適應症。電腦輔助藥物重定位系統是一個技術平台，它利用人工智慧、機器學習和資料探勘技術，系統地分析現有藥物、化合物和生物資料。例如，2023年11月，總部位於美國的基於人工智慧的精準醫療解決方案提供商Tempus宣布與總部位於美國的臨床階段生物技術公司Recursion達成一項價值高達1.6億美元的多年戰略合作協議。透過此次合作，Recursion將獲得Tempus龐大的匿名化多模態腫瘤資料資料庫，以支援主導生物標記的治療開發。透過將 Tempus 的大型患者資料集與 Recursion 的人工智慧驅動的藥物發現能力相結合，該夥伴關係將加強腫瘤學領域的藥物重新定位舉措，展示先進的計算平台和真實世界臨床數據的融合如何加速發現新的治療機會。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球人工智慧（AI）賦能藥物重定位市場：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球人工智慧藥物重定位市場：成長率分析
  • 全球人工智慧藥物重定位市場表現：規模與成長，2019-2024年
  • 全球人工智慧藥物重定位市場預測：規模與成長，2024-2029年，2034年
  • 全球人工智慧（AI）賦能藥物重定位市場：潛在市場規模（TAM）

第6章 市場細分

  • 全球藥物重定位人工智慧市場：按組件、性能和預測分類，2019-2024年、2024-2029年、2034年
  • 軟體和平台
  • 服務
  • 全球人工智慧藥物重定位市場：依技術、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 機器學習或深度學習
  • 自然語言處理（NLP）
  • 知識圖譜和基於網路的人工智慧
  • 生成式人工智慧和大規模語言模型（LLM）
  • 電腦視覺
  • 全球人工智慧藥物重定位市場：部署、效能與預測（2019-2024年、2024-2029年、2034年）
  • 雲端基礎的
  • 本地部署
  • 全球藥物重定位人工智慧市場依治療領域分類，表現及預測（2019-2024年、2024-2029年、2034年）
  • 腫瘤學
  • 神經病學
  • 心血管疾病
  • 感染疾病
  • 免疫學
  • 代謝性疾病
  • 罕見疾病
  • 全球人工智慧藥物重定位市場（依最終用戶、效能和預測分類，2019-2024年、2024-2029年、2034年）
  • 製藥和生物技術公司
  • 受託研究機構（CRO）
  • 學術研究機構
  • 醫療保健提供者
  • 其他
  • 全球藥物重定位人工智慧市場：軟體和平台細分、按類型分類、實際結果和預測（2019-2024 年、2024-2029 年、2034 年）
  • 預測分析工具
  • 機器學習框架
  • 數據整合系統
  • 藥物發現平台
  • 臨床試驗模擬工具
  • 全球藥物重定位人工智慧市場：服務細分、按類型分類、實際結果和預測（2019-2024年、2024-2029年、2034年）
  • 諮詢服務
  • 資料管理服務
  • 模型訓練與最佳化服務
  • 實施和整合服務
  • 支援和維護服務

第7章 區域和國家分析

  • 全球人工智慧藥物重定位市場：按地區、績效和預測分類，2019-2024年、2024-2029年、2034年
  • 全球人工智慧藥物重定位市場：按國家、績效和預測（2019-2024 年、2024-2029 年、2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 人工智慧在藥物重定位市場的應用：競爭格局
  • 人工智慧在藥物重定位市場的應用：公司概況
    • IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Evogene Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Ginkgo Bioworks Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • BioAge Labs Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Insilico Medicine Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • BostonGene Corporation
  • ISOMORPHIC LABS
  • Recursion Pharmaceuticals Inc.
  • Deep Genomics Inc.
  • Healx Ltd.
  • Owkin Inc.
  • BullFrog AI Holdings Inc.
  • Aicura Medical GmbH
  • Kantify
  • Ignota Labs Ltd.
  • OrphAI Therapeutics
  • Nabla Bio
  • Atomwise Inc.
  • BioXcel Therapeutics Inc.
  • Graph AI

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年人工智慧在藥物重定位市場的應用：提供新機會的國家
  • 2029年人工智慧在藥物重定位市場的應用：提供新機會的細分領域
  • 2029年人工智慧在藥物重定位市場的應用：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r39458

Artificial intelligence in drug repurposing refers to the use of artificial intelligence techniques to identify new medical applications for existing drugs. It applies advanced data analytics, machine learning, and predictive modeling to examine biological, chemical, and clinical data for potential therapeutic matches. This approach speeds up drug discovery, lowers research costs, and improves the efficiency of pharmaceutical development.

The primary components of artificial intelligence in drug repurposing include software and platforms and services. Software and platforms consist of digital tools and environments that facilitate the development, deployment, and utilization of applications and services. It employs various technologies such as machine learning or deep learning, natural language processing, knowledge graphs and network-based artificial intelligence, generative artificial intelligence and large language models, and computer vision. The different deployment modes include cloud-based and on-premises. Various therapeutic areas include oncology, neurology, cardiovascular diseases, infectious diseases, immunology, metabolic disorders, and rare diseases, and they serve several end-users, including pharmaceutical and biotechnology companies, contract research organizations, academic and research institutes, healthcare providers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are significantly impacting the information technology sector, particularly in hardware manufacturing, data infrastructure, and software deployment. Higher duties on imported semiconductors, circuit boards, and networking equipment have raised production and operational costs for tech firms, cloud service providers, and data centers. Companies relying on globally sourced components for laptops, servers, and consumer electronics are facing longer lead times and increased pricing pressures. In parallel, tariffs on specialized software tools and retaliatory measures from key international markets have disrupted global IT supply chains and reduced overseas demand for U.S.-developed technologies. To navigate these challenges, the sector is accelerating investments in domestic chip fabrication, diversifying supplier bases, and adopting AI-driven automation to enhance operational resilience and cost efficiency.

The artificial intelligence in drug repurposing market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in drug repurposing market statistics, including artificial intelligence in drug repurposing industry global market size, regional shares, competitors with a artificial intelligence in drug repurposing market share, detailed artificial intelligence in drug repurposing market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in drug repurposing industry. This artificial intelligence in drug repurposing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence in drug repurposing market size has grown exponentially in recent years. It will grow from $0.87 billion in 2024 to $1.05 billion in 2025 at a compound annual growth rate (CAGR) of 20.5%. The growth during the historic period can be attributed to the increasing prevalence of chronic and rare diseases, the rising research and development expenditure, the growing regulatory support, the rising healthcare costs, and the increasing collaborations between pharmaceutical companies and artificial intelligence firms.

The artificial intelligence in drug repurposing market size is expected to see exponential growth in the next few years. It will grow to $2.19 billion in 2029 at a compound annual growth rate (CAGR) of 20.2%. The growth during the forecast period can be attributed to the growing demand for cost-effective drug development, the increasing use of artificial intelligence-powered predictive analytics, the rising prevalence of complex diseases, the growing adoption of cloud infrastructure, and the increasing repurposing opportunities for existing approved drugs. Key trends in the forecast period include innovations in machine learning and generative artificial intelligence applications, developments in predictive modeling and data analytics, technological advancements in large language models for hypothesis generation, innovations in cloud-based artificial intelligence drug discovery platforms, and technological enhancements in multi-omics data integration systems.

The increasing demand for precision medicine is expected to drive the growth of the artificial intelligence in drug repurposing market in the coming years. Precision medicine is a healthcare approach that customizes disease prevention and treatment based on an individual's unique genes, behaviors, and environment. The growing preference for personalized treatments is fueling the expansion of precision medicine, as patients and healthcare providers increasingly seek therapies tailored to individual genetic and lifestyle profiles for improved effectiveness and fewer side effects. Artificial intelligence-driven drug repurposing supports precision medicine by identifying existing drugs that match an individual's genetic or molecular characteristics, enabling more accurate and personalized treatment solutions. For example, in February 2024, according to the Personalized Medicine Coalition, a United States-based nonprofit organization, the Food and Drug Administration approved sixteen personalized therapies targeting rare diseases in 2023, a significant increase compared to six approvals in 2022. Therefore, the rising demand for precision medicine is propelling the growth of the artificial intelligence in drug repurposing market.

Key companies operating in the artificial intelligence in drug repurposing market are concentrating on integrating advanced technologies in drug repositioning, such as computational drug repositioning systems, which systematically identify new therapeutic indications for existing drugs using data-driven analysis of literature and biological information. A computational drug repositioning system refers to a technology-based platform that employs artificial intelligence, machine learning, and data mining to systematically analyze existing drugs, compounds, and biological data. For instance, in November 2023, Tempus, a United States-based provider of artificial intelligence-based precision medicine solutions, announced a multi-year strategic collaboration with Recursion, a United States-based clinical-stage biotechnology company, valued at up to one hundred sixty million dollars over five years. The collaboration grants Recursion access to Tempus' extensive library of de-identified, multimodal oncology data to support biomarker-driven therapeutic development. By leveraging Tempus' large-scale patient datasets alongside Recursion's artificial intelligence-enabled discovery capabilities, the partnership strengthens oncology drug repurposing initiatives, demonstrating how advanced computational platforms combined with real-world clinical data can accelerate the identification of new treatment opportunities.

In January 2024, Cosmos Health Incorporated, a United States-based diversified healthcare company, acquired Cloudscreen for an undisclosed amount. Through this acquisition, Cosmos Health aims to strengthen drug repurposing capabilities and speed up the identification of new therapeutic applications for existing drugs. Cloudscreen is a United States-based company specializing in artificial intelligence-powered drug repurposing solutions.

Major players in the artificial intelligence in drug repurposing market are IBM Corporation, Evogene Ltd., Ginkgo Bioworks Holdings Inc., BioAge Labs Inc., Insilico Medicine Inc., BostonGene Corporation, ISOMORPHIC LABS, Recursion Pharmaceuticals Inc., Deep Genomics Inc., Healx Ltd., Owkin Inc., BullFrog AI Holdings Inc., Aicura Medical GmbH, Kantify, Ignota Labs Ltd., OrphAI Therapeutics, Nabla Bio, Atomwise Inc., BioXcel Therapeutics Inc., and Graph AI.

North America was the largest region in the artificial intelligence in drug repurposing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence in drug repurposing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the artificial intelligence in drug repurposing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence in drug repurposing market includes revenues earned by entities by providing services such as predictive modelling, target identification, drug-disease interaction analysis, virtual screening, and clinical data mining. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence In Drug Repurposing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence in drug repurposing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence in drug repurposing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence in drug repurposing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Software And Platforms; Services
  • 2) By Technology: Machine Learning Or Deep Learning; Natural Language Processing (NLP); Knowledge Graphs And Network-Based Artificial Intelligence; Generative Artificial Intelligence And Large Language Models (LLMs); Computer Vision
  • 3) By Deployment: Cloud-Based; On-Premises
  • 4) By Therapeutic: Oncology; Neurology; Cardiovascular Diseases; Infectious Diseases; Immunology; Metabolic Disorders; Rare Diseases
  • 5) By End-User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations (CROs); Academic And Research Institutes; Healthcare Providers; Other End-Users
  • Subsegments:
  • 1) By Software And Platforms: Predictive Analytics Tools; Machine Learning Frameworks; Data Integration Systems; Drug Discovery Platforms; Clinical Trial Simulation Tools
  • 2) By Services: Consulting Services; Data Management Services; Model Training And Optimization Services; Implementation And Integration Services; Support And Maintenance Services
  • Companies Mentioned: IBM Corporation; Evogene Ltd.; Ginkgo Bioworks Holdings Inc.; BioAge Labs Inc.; Insilico Medicine Inc.; BostonGene Corporation; ISOMORPHIC LABS; Recursion Pharmaceuticals Inc.; Deep Genomics Inc.; Healx Ltd.; Owkin Inc.; BullFrog AI Holdings Inc.; Aicura Medical GmbH; Kantify; Ignota Labs Ltd.; OrphAI Therapeutics; Nabla Bio; Atomwise Inc.; BioXcel Therapeutics Inc.; Graph AI.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence In Drug Repurposing Market Characteristics

3. Artificial Intelligence In Drug Repurposing Market Trends And Strategies

4. Artificial Intelligence In Drug Repurposing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence In Drug Repurposing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Artificial Intelligence In Drug Repurposing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Artificial Intelligence In Drug Repurposing Market Growth Rate Analysis
  • 5.4. Global Artificial Intelligence In Drug Repurposing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Artificial Intelligence In Drug Repurposing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Artificial Intelligence In Drug Repurposing Total Addressable Market (TAM)

6. Artificial Intelligence In Drug Repurposing Market Segmentation

  • 6.1. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software And Platforms
  • Services
  • 6.2. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Machine Learning Or Deep Learning
  • Natural Language Processing (NLP)
  • Knowledge Graphs And Network-Based Artificial Intelligence
  • Generative Artificial Intelligence And Large Language Models (LLMs)
  • Computer Vision
  • 6.3. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cloud-Based
  • On-Premises
  • 6.4. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology
  • Neurology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Immunology
  • Metabolic Disorders
  • Rare Diseases
  • 6.5. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic And Research Institutes
  • Healthcare Providers
  • Other End-Users
  • 6.6. Global Artificial Intelligence In Drug Repurposing Market, Sub-Segmentation Of Software And Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Predictive Analytics Tools
  • Machine Learning Frameworks
  • Data Integration Systems
  • Drug Discovery Platforms
  • Clinical Trial Simulation Tools
  • 6.7. Global Artificial Intelligence In Drug Repurposing Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consulting Services
  • Data Management Services
  • Model Training And Optimization Services
  • Implementation And Integration Services
  • Support And Maintenance Services

7. Artificial Intelligence In Drug Repurposing Market Regional And Country Analysis

  • 7.1. Global Artificial Intelligence In Drug Repurposing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Artificial Intelligence In Drug Repurposing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence In Drug Repurposing Market

  • 8.1. Asia-Pacific Artificial Intelligence In Drug Repurposing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence In Drug Repurposing Market

  • 9.1. China Artificial Intelligence In Drug Repurposing Market Overview
  • 9.2. China Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence In Drug Repurposing Market

  • 10.1. India Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence In Drug Repurposing Market

  • 11.1. Japan Artificial Intelligence In Drug Repurposing Market Overview
  • 11.2. Japan Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence In Drug Repurposing Market

  • 12.1. Australia Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence In Drug Repurposing Market

  • 13.1. Indonesia Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence In Drug Repurposing Market

  • 14.1. South Korea Artificial Intelligence In Drug Repurposing Market Overview
  • 14.2. South Korea Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence In Drug Repurposing Market

  • 15.1. Western Europe Artificial Intelligence In Drug Repurposing Market Overview
  • 15.2. Western Europe Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence In Drug Repurposing Market

  • 16.1. UK Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence In Drug Repurposing Market

  • 17.1. Germany Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence In Drug Repurposing Market

  • 18.1. France Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence In Drug Repurposing Market

  • 19.1. Italy Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence In Drug Repurposing Market

  • 20.1. Spain Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence In Drug Repurposing Market

  • 21.1. Eastern Europe Artificial Intelligence In Drug Repurposing Market Overview
  • 21.2. Eastern Europe Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence In Drug Repurposing Market

  • 22.1. Russia Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence In Drug Repurposing Market

  • 23.1. North America Artificial Intelligence In Drug Repurposing Market Overview
  • 23.2. North America Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence In Drug Repurposing Market

  • 24.1. USA Artificial Intelligence In Drug Repurposing Market Overview
  • 24.2. USA Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence In Drug Repurposing Market

  • 25.1. Canada Artificial Intelligence In Drug Repurposing Market Overview
  • 25.2. Canada Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence In Drug Repurposing Market

  • 26.1. South America Artificial Intelligence In Drug Repurposing Market Overview
  • 26.2. South America Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence In Drug Repurposing Market

  • 27.1. Brazil Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence In Drug Repurposing Market

  • 28.1. Middle East Artificial Intelligence In Drug Repurposing Market Overview
  • 28.2. Middle East Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence In Drug Repurposing Market

  • 29.1. Africa Artificial Intelligence In Drug Repurposing Market Overview
  • 29.2. Africa Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence In Drug Repurposing Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Intelligence In Drug Repurposing Market Competitive Landscape
  • 30.2. Artificial Intelligence In Drug Repurposing Market Company Profiles
    • 30.2.1. IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Evogene Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Ginkgo Bioworks Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. BioAge Labs Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Insilico Medicine Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence In Drug Repurposing Market Other Major And Innovative Companies

  • 31.1. BostonGene Corporation
  • 31.2. ISOMORPHIC LABS
  • 31.3. Recursion Pharmaceuticals Inc.
  • 31.4. Deep Genomics Inc.
  • 31.5. Healx Ltd.
  • 31.6. Owkin Inc.
  • 31.7. BullFrog AI Holdings Inc.
  • 31.8. Aicura Medical GmbH
  • 31.9. Kantify
  • 31.10. Ignota Labs Ltd.
  • 31.11. OrphAI Therapeutics
  • 31.12. Nabla Bio
  • 31.13. Atomwise Inc.
  • 31.14. BioXcel Therapeutics Inc.
  • 31.15. Graph AI

32. Global Artificial Intelligence In Drug Repurposing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence In Drug Repurposing Market

34. Recent Developments In The Artificial Intelligence In Drug Repurposing Market

35. Artificial Intelligence In Drug Repurposing Market High Potential Countries, Segments and Strategies

  • 35.1 Artificial Intelligence In Drug Repurposing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Artificial Intelligence In Drug Repurposing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Artificial Intelligence In Drug Repurposing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer